Sort
326,823 grants matching “clinical trial”
IGF::OT::IGF PURPOSE: TO AWARD THE BASE PERIOD FOR CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN POP: 08/14/2015-08/13/2016.
$4,069,454Robert Lindblad · The Emmes Company, Llc · N01 · FY2015 · DA
CREST-2 Clinical Coordinating Center
$4,069,399Thomas G Brott · Mayo Clinic Jacksonville · U01 · FY2020 · NS
IGF::OT::IGF PURPOSE: TO AWARD THE BASE PERIOD FOR CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN POP: 08/14/2015-08/13/2016.
$4,069,381Robert Lindblad · The Emmes Company, Llc · N01 · FY2016 · DA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
$4,069,353University Of Southern California · P30 · FY2000 · CA
IGF::OT::IGF PURPOSE: TO AWARD THE BASE PERIOD FOR CLINICAL RESEARCH COORDINATING CENTER FOR THE NIDA CTN POP: 08/14/2015-08/13/2016.
$4,069,336Robert Lindblad · The Emmes Company, Llc · N01 · FY2017 · DA
ECOG - ACRIN CCOP RESEARCH BASE GRANT - CORE
$4,068,148Robert L Comis · Drexel University · U10 · FY2012 · CA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$4,067,524Eric S. Orwoll · Oregon Health & Science University · UL1 · FY2010 · RR
Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication
$4,067,228Xinhua Li · Clear Scientific, Llc · U01 · FY2022 · DA
PERU Clinical Trial Unit
$4,067,059Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2021 · AI
SSCOR in Pediatric Heart Development and Disease
$4,066,725Children'S Hospital Boston · P50 · FY2005 · HL
Exploring pathophysiologic mechanisms to assess risk and optimize treatment outcomes in patients with mitral regurgitation
$4,066,506Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · HL
Physical Exercise to Prevent Disability Pilot Study
$4,066,020Wake Forest University Health Sciences · U01 · FY2004 · AG
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$4,065,402Jill Frankenfield · University Of Maryland Baltimore · N01 · FY2025 · AI
Specialized Cancer Center Support Grant (CCSG)
$4,065,117University Of California San Diego · P30 · FY2004 · CA
Institute for Clinical and Translational Science
$4,065,081Eric J Vilain · University Of California-Irvine · UM1 · FY2025 · TR
CTN CLINICAL COORDINATING CENTER SUPPORT; POP 08/14/20-08/13/21
$4,064,070Robert Lindblad · The Emmes Company, Llc · N01 · FY2020 · DA
Frontiers: University of Kansas Clinical and Translational Science Institute
$4,063,704Richard J. Barohn · University Of Kansas Medical Center · UL1 · FY2017 · TR
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$4,062,344Judith S. Currier · University Of California Los Angeles · UM1 · FY2020 · AI
Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?
$4,061,892Kyle Matthew Kampman · University Of Pennsylvania · UG3 · FY2019 · DA
Childhood Onset Schizophrenia
$4,060,885Judith L. Rapoport · National Institute Of Mental Health · ZIA · FY2013 · MH
Biostatistical Center for the NSABP
$4,058,481Joseph P. Costantino · University Of Pittsburgh At Pittsburgh · U10 · FY2006 · CA
Center to Improve Chronic disease Outcomes through Multi-level and Multi-generational approaches Unifying Novel Interventions and Training for health EquitY (The COMMUNITY Center)
$4,058,416Mary Beth Terry · Columbia University Health Sciences · P50 · FY2022 · MD
Novel Adenovirus Vector-Based Vaccines for HIV-1
$4,058,366Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2007 · AI
EMB-001: A novel combination therapy for the treatment of cocaine-use disorder
$4,057,614Michael J. Detke · Embera Neurotherapeutics, Inc. · U01 · FY2016 · DA
Adoptive Cell Transfer Immunotherapy of Cancer
$4,057,426Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA